Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons. The company's platform of unique molecular entities selectively affects inflamed nociceptors.

Nocion Therapeutics

Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons. The company’s platform of unique molecular entities selectively affects inflamed nociceptors. Treatment using this approach aims to provide more durable and robust local analgesic effects while minimizing numbness or paralysis and other systemic off-target effects. The company’s mission is to safely alleviate suffering for millions of patients with conditions arising from activated sensory neurons including chronic cough, pain and itch.

F-Prime Capital

Partners Innovation Fund

Mission BioCapital

Canaan Partners

Nocion Therapeutics, Inc.

“We scrambled, got back, revived from the dead, if you will, and then worked again to bring in the right syndicate for this."

Boston-area biotech Nocion Therapeutics, Inc. has raised $62 million to bring its capsule-based inhaler toward Phase III testing, CEO Rick Batycky told Endpoints News. 

The startup is attempting to treat chronic cough, a condition that lasts at least eight weeks and has become more stigmatized as a result of the Covid-19 pandemic. 

"It can make you feel like a social outcast,” said Julie Grant, a general partner at Nocion investor Canaan Partners.

More on how Nocion plans to treat chronic cough with a different approach than GSK (by way of Bellus) and Merck: 

#cough #drugdevelopment #biotech #venturecapital 

We are thrilled to announce we have raised $62 million in Series B funding which will allow us to complete a Phase 2b study in Chronic Cough. Thank you to our new and existing investors for making this possible. 
https://lnkd.in/esqVrNTZ


msh id	COM:NOCIONTX
symbol	-
name	Nocion Therapeutics
homepage url	https://nociontx.com
country	US
sector	8
industry	Healthcare & Health Services
market	PRIVATE
employee count	14
crunchbase url	https://www.crunchbase.com/organization/nocion-therapeutics
linkedin url	https://www.linkedin.com/company/nocion-therapeutics-inc
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	43.51
growth score 28	13.25
growth score 90	5.45
growth score 365	46.3

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

COM:NOCIONTX

Nocion Therapeutics

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-